Ischemic and hemorrhagic complications after intra-arterial fibrinolysis in vertebrobasilar occlusion

American Journal of Neuroradiology

Volumn 28, Issue 2, 2007, Pages 378-381

  Schulte Altedorneburg, Gernot ^a,e   Bruckmann H ^a   Hamann, G F ^a,d   Mull, M ^b   Liebetrau, M ^a,d   Weber, W ^c   Kuhne D ^c   Mayer, T E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c ALFRIED KRUPP KRANKENHAUS   (Germany)

^d DR HORST SCHMIDT KLINIKEN   (Germany)

^e SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; DRUG MEGADOSE; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; POSTERIOR CEREBRAL ARTERY; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; THALAMUS; THROMBECTOMY; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR; VERTEBROBASILAR INSUFFICIENCY;

EID: 33847139681     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Labauge R, Pages M, Blard JM. Survie prolongee apres occlusion du tronc basilaire. Rev Neurol 1981;145:789-94
2. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216-22
3. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999;45:539-48
4. Schulte-Altedorneburg G, Hamann GF, Mull M, et al. Outcome of acute vertebrobasilar occlusions treated with local intra-arterial fibrinolysis in 180 cases. AJNR Am J Neuroradiol 2006;27:2042-47.
5. Eckert B, Kucinski T, Pfeiffer G, et al. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14:42-50
6. Cross DT, Derdeyn CP, Moran CJ. Bleeding complications after basilar artery fibrinolysis with tissue plasminogen activator. AJNR Am J Neuroradiol 2001;22:521-25
7. Anonymous. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-36
8. Zeumer H, Freitag HJ, Zanella F, et al. Local intra-arterial fibrinolytic therapy in patients with stroke: urokinase versus recombinant tissue plasminogen activator (rtPA). Neuroradiology 1993;35:159-62
9. Gulba DC, Bode C, Runge MS, et al. Thrombolytic agents-an overview. Ann Hematol 1996;73(Suppl. 11):S9-27
10. del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
11. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study, a randomized controlled trial. JAMA 1999;282:2003-11
12. Arnold M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 2002;33:1828-33
13. Eckert B, Kucinski T, Neumaier-Probst E, et al. Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome. Cerebrovasc Dis 2003;15:258-63
14. Brandt T, von Kummer R, Muller Kuppers M, et al. Thrombolytic therapy of acute basilar artery occlusion: variables affecting recanalization and outcome. Stroke 1996;27:875-81
15. Arnold M, Nedeltchev K, Schroth G, et al. Clinical and radiological predictors of recanalization and outcome of 40 patients with acute basilar artery occlusion treated with ultra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857-62
16. Anonymous. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med 1995;333:1581-87
17. Mayer TE, Hamann GF, Brueckmann H. Treatment of basilar artery embolism with mechanical extraction device: necessity of flow reversal. Stroke 2002;33:2232-35
18. Mayer TE, Hamann GF, Schulte-Altedorneburg G, et al. Treatment of vertebro-basilar occlusion by using a coronary waterjet thrombectomy device: a pilot study. AJNR Am J Neuroradiol 2005;26:1389-94
19. Nesbit GM, Luh G, Tien R, et al. New and future endovascular treatment strategies for acute ischemic stroke. J Vasc Interv Radiol 2004:15:S103-10
20. Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion. Combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST)-results of a multicenter study. Stroke 2005;36:1160-65
21. Bergui M, Stura G, Daniele D, et al. Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first line treatment. Stroke 2006;37:145-50.
22. Wikholm G. Transarterial embolectomy in acute stroke. AJNR Am J Neuroradiol 2003;24:892-94
23. Mangiafico S, Cellerini M, Nencini P, et al. Intravenous glycoprotein IIb/IIIa inhibitor (Tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 2005;26:2595-601